United States ex rel. Palmieri v. Alpharma, Inc.

647 F. App'x 166
CourtCourt of Appeals for the Fourth Circuit
DecidedApril 26, 2016
DocketNo. 14-1388
StatusPublished
Cited by4 cases

This text of 647 F. App'x 166 (United States ex rel. Palmieri v. Alpharma, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. Palmieri v. Alpharma, Inc., 647 F. App'x 166 (4th Cir. 2016).

Opinion

Vacated and remanded by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Relator Jerome Palmieri appeals the district court’s dismissal of his qui tam complaint against his former employer, Alpharma, Inc., and associated companies (collectively, “Defendants”), under the False Claims Act (“FCA”). The district court dismissed Palmieri’s complaint pursuant to Fed.R.Civ.P. 9(b), for failure to plead his claims of fraud with sufficient particularity. In so ruling, the district court did not address Defendants’ arguments that Palmieri’s claims were precluded by the FCA’s first-to-file bar, 31 U.S.C. § 3730(b)(5) (2006),

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
647 F. App'x 166, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-palmieri-v-alpharma-inc-ca4-2016.